ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,892.00
      -0.54%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.13
      -0.89%
      Bitcoin
      57,044.42
      -5.87%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. PharmaCyte Biotech Inc (PMCB)

      7. PharmaCyte Biotech Inc (PMCB) News

      PMCB

      PharmaCyte Biotech (PMCB)

      PharmaCyte Biotech Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PMCB
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      02/14/20243:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMCBPharmaCyte Biotech Inc
      02/06/20249:56AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
      12/15/20235:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
      11/28/20235:06PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
      11/24/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
      11/22/20235:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
      11/22/20235:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
      11/22/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
      11/22/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
      11/22/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
      11/22/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
      11/22/20234:00PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PMCBPharmaCyte Biotech Inc
      11/15/20238:30AMBusiness WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:PMCBPharmaCyte Biotech Inc
      11/09/20235:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
      10/31/20239:15AMBusiness WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
      10/31/20239:15AMBusiness WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
      10/02/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PMCBPharmaCyte Biotech Inc
      09/21/20235:04PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
      09/18/20236:04AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
      09/15/20235:00PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PMCBPharmaCyte Biotech Inc
      09/11/20239:56PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
      09/07/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
      08/04/20234:40PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
      08/04/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
      07/31/20235:18PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PMCBPharmaCyte Biotech Inc
      07/31/20234:42PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
      07/19/202310:28AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
      06/16/20235:23PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PMCBPharmaCyte Biotech Inc
      06/15/20234:02PMEdgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:PMCBPharmaCyte Biotech Inc
       Showing the most relevant articles for your search:NASDAQ:PMCB